DMAA Approves New Board Members SAN DIEGO, Calif.—The Disease Management Association of America (DMAA) today announced the appointment of three new members to the Board of Directors. The new DMAA Board of Directors members include: Christopher Coloian, Vice President, Disease Management, CIGNA Health Care; Freida Hopkins Outlaw, PhD, Executive Director for Special Populations, Tennessee Department of Mental Health and Developmental Disabilities; and John Sory, Vice President, Pfizer Health Solutions. Each new director will serve a three-year term on the DMAA Board. "DMAA is pleased to welcome these three highly qualified individuals to our Board. These individuals bring both expertise and diversity to DMAA and will enhance our ability to advance our research and advocacy efforts, expand our membership, and enhance our program offerings," said Ms. Christobel Selecky, President, DMAA. In addition to the new Board Members confirmed by DMAA members at the annual business meeting, DMAA also affirmed a one year-term extension for the current executive office holders. Current DMAA officers include:
Based in Washington, DC, the Disease Management Association of America is a nonprofit, voluntary membership organization, founded in March of 1999, which represents all stakeholders in the disease management community. For more information, please visit www.dmaa.org. # # # |